Ablative Radiotherapy to Consolidate Maximal Systemic Response in Metastatic Prostate Cancer (ANCHOR-Prostate)

Clinical trial NCT05457699 · RECRUITING

Trial details

NCT number: NCT05457699
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Metastatic

Start date: 2022-12-30
Primary completion: 2030-07-30
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.